We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| 111 Inc | NASDAQ:YI | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | -4.07% | 1.18 | 1.17 | 1.31 | 1.24 | 1.16 | 1.20 | 16,276 | 21:53:50 |
From Jun 2022 to Jun 2024
By Bingyan Wang
Nasdaq-listed 111 Inc. has started retail sales of Pfizer Inc.'s oral Covid-19 treatment pill in China, according to the healthcare platform's website.
The sales page on the Chinese platform on Tuesday showed it is now offering Paxlovid, the Covid-19 medication that Beijing approved in February, for customers with positive polymerase chain reaction or antigen test results.
Pfizer started manufacturing Paxlovid in 2021.
Paxlovid has been used by medical practitioners to treat patients in China since March, when Shanghai was hit by a Covid-19 outbreak, according to local media reports.
Write to Bingyan Wang at bingyan.wang@wsj.com
(END) Dow Jones Newswires
December 13, 2022 06:03 ET (11:03 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year 111 Chart |
1 Month 111 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
